Learn About Available CCPM Biobank Research Study Resources

Managed by CCPM, the CCPM biobank research study contains genetic information, biospecimens and clinical data from consenting participants across the UCHealth system. The primary goal of the CCPM biobank research study is to aid discoveries in personalized medicine by understanding individual differences and their impact on health and disease. 

 All data provided through Access to Biobank Committee (ABC) processes is intended solely for research purposes. It is not validated for clinical decision-making, diagnostic use or therapeutic guidance. Users must not interpret or apply this information in any clinical context. 

Investigators can request access to any combination of the following CCPM biobank research study resources:

CCPM Biobank Research Study Data Resources

CCPM Biobank Research Study Biospecimen Resources

The CCPM biobank clinically stores purified genomic DNA. Researchers can request aliquoted gDNA following guidelines set forth by the Colorado Multiple Institutional Review Board (COMIRB) and the College of American Pathologists (CAP).

To request access to CCPM biobank genomic DNA, submit an Access to Biobank Committee (ABC) proposal request here

CCPM Biobank Research Study Participant Recontact Resources

Recruit CCPM biobank research study participants into your study. The CCPM biobank research study offers investigators the opportunity to recruit from its pool of engaged research participants, many of whom have available genotype data and DNA samples. This resource may support recruitment efforts for studies seeking to recruit participants with genotype data available or based on specific genetic profiles.

To request access to recontact CCPM biobank research study participants, submit an Access to Biobank Committee (ABC) proposal request here


*Please note: The ABC offers multiple data products created from multiple datasets. Some of the data products are generated from our partnership with Regeneron Genetics Center (RGC). This includes whole exome sequencing (WES) for ~95,500 individuals across 8.6 million and some past research freezes. RGC requires that any publication, presentation, abstract, poster, grant application, manuscript submission or any other scientific communication outside of the University of Colorado Anschutz Medical Campus be submitted to RGC 30 days in advance for approval. If you would like to use WES, you must agree to these terms and conditions.

editing pen Request an edit to this webpage here.
biobank-uchealth-cu-logo

Colorado Center for Personalized Medicine

University of Colorado Anschutz Medical Campus

CU Anschutz

Anschutz Health Sciences Building

1890 N Revere Ct

Mailstop F563

Aurora, CO 80045


CMS Login